Genetic test could 'hugely improve' prognosis for esophageal cancer
7/01/2014
A novel non-invasive test that looks for two gene mutations that mark progression of Barrett’s esophagus to cancer could hugely improve prognosis for an otherwise deadly cancer.
New data from FIRE-3 study shows significant improvement in tumour response and shrinkage
7/01/2014
New data, presented at the 16th World Congress on Gastrointestinal Cancer (WCGC), has shown significantly higher overall response rate (ORR) (72.5% vs. 55.5%) (p=0.
Scientists engineer nanoparticles to prevent bone cancer and strengthen bones
7/01/2014
A research collaboration between Brigham and Women's Hospital (BWH) and Dana-Farber Cancer Institute (DFCI) has utilized nanomedicine technologies to develop a drug-delivery system that can...
More than 40 melanoma-specific genes discovered that determine cancer aggressiveness
7/01/2014
The results of the study could help to determine the development of metastasis in patients suffering from the disease.
In aggressive and non-aggressive lymphatic system cancer just a single gene separates the two
7/01/2014
For a rare form of cancer called thymoma, researchers have discovered a single gene defining the difference between a fast-growing tumor requiring aggressive treatment and a slow-growing tumor that...
Cell's unique mutations used to trace history back to its origins in the embryo
7/01/2014
Researchers have developed new methods to trace the life history of individual cells back to their origins in the fertilised egg.
Breast cancer and other aggressive cancers may respond to anti-inflammatory drugs
7/01/2014
New research raises the prospect that some cancer patients with aggressive tumors may benefit from a class of anti-inflammatory drugs used to treat rheumatoid arthritis.
Abnormal blood clots in the brain offer drug target for Alzheimer's
7/01/2014
Without a steady supply of blood, neurons can't work. That's why one of the culprits behind Alzheimer's disease is believed to be the persistent blood clots that often form in the brains of...
In KRAS wild-type MCRC, equivalent survival offered by cetuximab or bevacizumab with combi chemo
7/01/2014
For patients with KRAS wild-type untreated colorectal cancer, adding cetuximab or bevacizumab to combination chemotherapy offers equivalent survival, researchers said at the ESMO 16th World Congress...
Back and abdomen pain an increased risk for colon cancer survivors
7/01/2014
Researchers from the University of Granada discover that colon cancer patients experience abnormalities in processing chronic pain that increase their sensitization to pain of any kind in the...